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Background: Surfactant proteins (SP) secreted by alveolar type 2 cells, play an essential role in maintaining the
air-liquid barrier of the lung and are also involved in the opsonisation and clearance of bacteria by phagocytes.
We have recently described a novel surfactant protein, SP-H (SFTA3). Expression of SP-H was earlier demonstrated
to be upregulated by LPS and negatively regulated by IL-1β and IL-23 in vitro. The influence of SP-H on phagocytosis
was measured using a murine and a human phagocytic cell line and fluorescent latex beads.
Findings: SP-H markedly increases phagocytosis in vitro in the murine-derived alveolar macrophage cell lines MH-S
and in human-derived differentiated U937 cells.
Conclusion: It can be assumed that SP-H is involved in regulating phagocytic activity of macrophages. SP-H is a new
player in pulmonary host defence.Background
Pulmonary surfactant proteins (SP) reduce the surface
tension at the air-liquid interface and act as collectins in
innate immunity. The lack of SPs leads to respiratory
failure. SP-A and SP-D bind to carbohydrates of bac-
teria, viruses, fungi and protozoa, opsonize them and
thereby accelerate their removal by phagocytes [1,2].
The role of SP-A in opsonisation and removal of
Staphylococcus aureus is well-known and was recently
confirmed in vivo by the decelerated phagocytosis of
S. aureus in SP-A deficient mice [3], although it has
recently been shown that S. aureus express and secrete
SPs as well [4]. Surfactant proteins B and C are involved
in the stabilization of phospholipids in the air-liquid
interface [5]. In addition to the four known surfactant
proteins SP-A, SP-B, SP-C and SP-D [6,7], a novel
surfactant protein called SFAT3 or SP-H was recently
identified by Schicht et al. in lung tissues [7]. This* Correspondence: thomas.tschernig@uks.eu
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unless otherwise stated.protein, with a molecular weight of 10 kDa, was first
detected by means of bioinformatics and subsequently
identified in human lung and bronchoalveolar lavage
at concentrations of 0.06–1.83 ng mg−1 and 0.15–
4.87 ng mg−1. Within lung tissue, SP-H is distributed
in alveolar type 1 and 2 cells, alveolar macrophages
and in the cytoplasm of the epithelium. Using the
alveolar cell line A549, an increase in SP-H expres-
sion was demonstrated as a response to cell stimula-
tion with bacterial lipopolysaccharide (LPS), in vitro.
In contrast, interleukin (IL)-1β and IL-23 caused the
down regulation of the SP-H mRNA in A549 cells.
This observation led the authors to the assumption
that SP-H might play a role in host defence against
gram negative bacteria [8]. In this study, we show
the phagocytosis efficiency increasing property of
SP-H.
Findings
For this purpose, we have used recombinant SP-H (GST
purification) and an in vitro phagocytosis assay as previ-
ously described [8,9]. The murine alveolar macrophages cell
line MH-S was obtained from Sigma-Aldrich (Germany).
Cells were grown in RPMI 1640 medium (Lonza, Germany)d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The phagocytosis efficiency of the alveolar macrophage cell line MH-S and the differentiated lymphoma cell line U937 as a
function of SP-H. The phagocytosis efficiency was determined by flow cytometry.
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Germany), 100 Units ml−1 penicillin, 100 μg ml−1 strepto-
mycin (both antibiotics from PAA, Germany) and 50 μM
β-mercaptoethanol (gibco life technologies, Darmstadt,
Germany) at 37°C in a humidified atmosphere with 5%
CO2. To detach the cells from culture flasks a few millili-
ters of a mixture of 500 μg ml−1 trypsin with 220 μg ml−1
EDTA were added to the adherent cells, which were then
incubated at 37°C for fifteen minutes. Cells were then
collected by centrifugation and resuspended in medium.
Then 0.5 × 106 or 1 × 106 cells were disseminated on 12
well-plates (Greiner Bio-One, Frickenhausen, Germany).
After 15 hours the cells were used for the phagocytosis
assay. The monocyte-like human lymphoma U937 cell line
was cultivated in RPMI 1640 medium with 10% fetal bovine
serum, 100 Units ml−1 penicillin and 100 μg ml−1 strepto-
mycin. For differentiation into adherent macrophage-like
cells capable of phagocytosis, cells were incubated with
50 ng ml−1 phorbol 12-myristate 13-acetate (PMA) (Sigma
Aldrich) for 20 hours, washed with medium once, and
then incubated in medium for 48 hours at 37°C in aFigure 2 The phagocytosis efficiency of the alveolar macrophage cell
function of SP-H after incubation in a mixture of three phagocytosis
significant. The phagocytosis efficiency was determined by flow cytometry.humidified atmosphere with 5% CO2. Subsequently the
cells were used for the phagocytosis assay. Fluoresbrite®
Yellow Green Microspheres (Polysciences GmbH,
Eppenheim, Germany) with a size of 1 μm were used for
phagocytosis assays in presence of 0, 100 ng ml−1,
250 ng ml−1, 500 ng ml−1 and 1000 ng ml−1 SP-H. After
120 min incubation, the cells were washed and the
percentage of the cells with ingested fluorescent beads was
determined using a flow cytometer (FACS Calibur, Beckton
Dickinson, Heidelberg, Germany). The assays were re-
peated twice with SP-H expressed in E.coli (n = 2) and
reproduced with SP-H expressed in mammalian cells (n =
2) (data not shown). The statistical significance (P < 0.05)
was analysed by ANOVA, Dunnett’s Multiple Comparison
test and Bonferronis Multiple Comparison test. For the first
posthoc test, the SP-H free cells served as reference values.
To determine the specifity of SP-H for the phagocytosis,
experiments were also conducted after incubating the
cells with three inhibitors, cytochalasin D (5 mg ml−1),
nocodazol (3 mg ml−1) and staurosporine (10 μM), previ-
ously revealed to inhibit phagocytosis significantly [9].line MH-S and the differentiated lymphoma cell line U937 as a
inhibitors: cytochalasin D, nocodazole, and staurosporine. Ns: not
Figure 3 Comparison of phagocytosis efficiencies in absence and presence of phagocytosis inhibitors cytochalasin D, nocodazole and
staurosporine. The data shows that treatment of the cells with a mixture of the inhibitors reduces phagocytosis efficiency significantly.
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by both cell lines was significantly enhanced by the
presence of the SP-H protein. The gradually increasing
concentration of the protein also caused a gradual in-
crease in phagocytosis efficiency. The results show that,
in the presence of 500 ng ml−1 and 1 μg ml−1 SP-H,
both cell lines are significantly stimulated to take up
particles (Figure 1). Obviously, the murine alveolar
macrophage cell line MH-S has a higher susceptibility
to SP-H than the human U937, which was initially
isolated from histocytic lymphoma [10]. In summary,
the findings of this study demonstrate an improving
effect of SP-H on the phagocytosis of latex particles by
macrophage like cell lines of human and of mouse ori-
gin. Especially the alveolar macrophage cell line MH-S
is highly stimulated by SP-H, even at a concentration of
100 ng ml−1, whereas the differentiated U937 cells
showed only slightly increased phagocytosis efficiency
at a five-fold higher concentration (500 ng ml−1). To
exclude that an increase in the relative fluorescence
intensity (RFI) measured by flow cytometer is caused by
an enhanced adherence of the polystyrene microspheres
to the cells, the assays were performed after incubation
of the cells with phagocytosis inhibitors. Figure 2 shows
that in the presence of the inhibitors, SP-H did not have
a phagocytosis efficiency increasing effect on MH-S
cells. In contrast, U937 cells treated with phagocytosis
inhibitors, showed a significant increase in their phago-
cytosis efficiency caused by 1 μg ml−1 SP-H. However,
the phagocytosis of the U937 cells with 1 μg ml−1 SP-H
treated with inhibitors is significantly lower than the U937
cells that were not treated with inhibitors (Figure 3).
Therefore, the increase in RFI values are attributable
to an enhanced phagocytosis efficiency, rather than to
improved adhesion of the beads to the cells.
Based on these results, we assume that one natural role
of SP-H is to enhance alveolar macrophage phagocytosis.
SP-H enhances the phagocytosis efficiency of the human-derived and the murine-derived macrophage cell lines for
polystrene microspheres. This suggests that SP-H could
be involved in foreign particle clearance and possibly into
pathogen clearance in vivo.
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